Table 6.
Zanamivir pharmacokinetics estimated from one- and two-compartment modelsa
Model | kel (h−1) | t1/2 (h) | V1 (liter/kg) | CL (liter/kg/h) | V2 (liter/kg) | CL2 (liter/kg/h) | AUC (ng/ml h) | Cmax (ng/ml) | tα1/2 (h) | tβ1/2 (h) |
---|---|---|---|---|---|---|---|---|---|---|
1 Compartment | 0.832 | 0.834 | 0.17 | 0.149 | 63,705 | 48,317 | ||||
0.669 | 0.588 | 0.127 | 0.11 | 56,589 | 35,854 | |||||
1.179 | 1.037 | 0.2 | 0.198 | 92,939 | 57,596 | |||||
2 Compartmentb | 0.939 | 0.127 | 0.119 | 0.09 | 0.174 | 79,489 | 49,271 | 0.165 | 1.428 | |
0.613 | 0.06 | 0.085 | 0.052 | 0.053 | 67,307 | 36,624 | 0.04 | 0.957 | ||
1.802 | 0.178 | 0.165 | 0.128 | 0.875 | 114,477 | 58,871 | 0.434 | 2.141 |
Median values are given in the top line of each row, and underneath are the range values. Regimen D, 600 mg zanamivir infused during 30 min. kel, elimination rate constant; t1/2, elimination half life (in a one-compartment model); V1, volume of the central (or only) compartment; CL, clearance from the central (or only) compartment; V2, volume of the second compartment; CL2, intercompartmental clearance; AUC, total area under the concentration-time curve; Cmax, maximum concentration; tα1/2, half life corresponding to the initial elimination phase (in a two-compartment model); tβ1/2, terminal elimination half life.
One subject was excluded, since the fit of the two-compartment model was poor.